Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Coral Laboratories
|
Sanjivani Paranteral
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.1 % | 6.99 % | -37.68 % |
|
5yr average Equity Multiplier
|
-1.22 | 1.2 | -1.69 |
|
5yr Average Asset Turnover Ratio
|
1.1 | 0.47 | 1.39 |
|
5yr Avg Net Profit Margin
|
-16.74 % | 12.64 % | 7.02 % |
|
Price to Book
|
0.0 | 1.22 | 9.34 |
|
P/E
|
0.0 | 9.16 | 41.57 |
|
5yr Avg Cash Conversion Cycle
|
-56.32 Days | 26.14 Days | -55.03 Days |
|
Inventory Days
|
94.46 Days | 79.65 Days | 28.68 Days |
|
Days Receivable
|
80.66 Days | 112.59 Days | 21.4 Days |
|
Days Payable
|
174.19 Days | 147.17 Days | 284.6 Days |
|
5yr Average Interest Coverage Ratio
|
-3.11 | 114.88 | 15.99 |
|
5yr Avg ROCE
|
-80.86 % | 8.79 % | -87.74 % |
|
5yr Avg Operating Profit Margin
|
-18.99 % | 11.85 % | 9.71 % |
|
5 yr average Debt to Equity
|
-1.55 | 0.03 | -0.72 |
|
5yr CAGR Net Profit
|
-9.68 % | 17.24 % | n/a |
|
5yr Average Return on Assets
|
-10.42 % | 5.83 % | 11.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.12 % | 71.51 % | 28.87 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
38.79 % | 0.0 | 1.52 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
Coral Laboratories
|
Sanjivani Paranteral
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|